198 related articles for article (PubMed ID: 24030251)
1. Advanced glycated end-products affect HIF-transcriptional activity in renal cells.
Bondeva T; Heinzig J; Ruhe C; Wolf G
Mol Endocrinol; 2013 Nov; 27(11):1918-33. PubMed ID: 24030251
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II differentially regulates Morg1 expression in kidney cells.
Bondeva T; Heinzig J; Franke S; Wolf G
Am J Nephrol; 2012; 35(5):442-55. PubMed ID: 22555025
[TBL] [Abstract][Full Text] [Related]
3. Morg1(+/-) heterozygous mice are protected from experimentally induced focal cerebral ischemia.
Stahr A; Frahm C; Kretz A; Bondeva T; Witte OW; Wolf G
Brain Res; 2012 Oct; 1482():22-31. PubMed ID: 22982595
[TBL] [Abstract][Full Text] [Related]
4. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3).
Hopfer U; Hopfer H; Jablonski K; Stahl RA; Wolf G
J Biol Chem; 2006 Mar; 281(13):8645-55. PubMed ID: 16407229
[TBL] [Abstract][Full Text] [Related]
5. Morg1 heterozygous mice are protected from acute renal ischemia-reperfusion injury.
Hammerschmidt E; Loeffler I; Wolf G
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1273-87. PubMed ID: 19726548
[TBL] [Abstract][Full Text] [Related]
6. MORG1
Bondeva T; Schindler C; Schindler K; Wolf G
BMC Nephrol; 2018 Feb; 19(1):29. PubMed ID: 29402223
[TBL] [Abstract][Full Text] [Related]
7. Morg1 heterozygous deficiency ameliorates hypoxia-induced acute renal injury.
Loeffler I; Wolf G
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F511-21. PubMed ID: 25550320
[TBL] [Abstract][Full Text] [Related]
8. Heterozygosity of mitogen-activated protein kinase organizer 1 ameliorates diabetic nephropathy and suppresses epithelial-to-mesenchymal transition-like changes in db/db mice.
Loeffler I; Liebisch M; Daniel C; Amann K; Wolf G
Nephrol Dial Transplant; 2017 Dec; 32(12):2017-2034. PubMed ID: 28992060
[TBL] [Abstract][Full Text] [Related]
9. Cloning of the Human
Bondeva T; Wolf G
Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327980
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
[TBL] [Abstract][Full Text] [Related]
11. DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney.
Samaan E; Ramadan NM; Abdulaziz HMM; Ibrahim D; El-Sherbiny M; ElBayar R; Ghattas Y; Abdlmalek J; Bayali O; Elhusseini Y; Maghrabia A; El-Gamal R
Biomed Pharmacother; 2023 Nov; 167():115629. PubMed ID: 37804810
[TBL] [Abstract][Full Text] [Related]
12. Expression of prolyl hydroxylases (PHDs) is selectively controlled by HIF-1 and HIF-2 proteins in nucleus pulposus cells of the intervertebral disc: distinct roles of PHD2 and PHD3 proteins in controlling HIF-1α activity in hypoxia.
Fujita N; Markova D; Anderson DG; Chiba K; Toyama Y; Shapiro IM; Risbud MV
J Biol Chem; 2012 May; 287(20):16975-86. PubMed ID: 22451659
[TBL] [Abstract][Full Text] [Related]
13. PHD3 is a transcriptional coactivator of HIF-1α in nucleus pulposus cells independent of the PKM2-JMJD5 axis.
Schoepflin ZR; Silagi ES; Shapiro IM; Risbud MV
FASEB J; 2017 Sep; 31(9):3831-3847. PubMed ID: 28495754
[TBL] [Abstract][Full Text] [Related]
14. Glomerular cell death and inflammation with high-protein diet and diabetes.
Meek RL; LeBoeuf RC; Saha SA; Alpers CE; Hudkins KL; Cooney SK; Anderberg RJ; Tuttle KR
Nephrol Dial Transplant; 2013 Jul; 28(7):1711-20. PubMed ID: 23314315
[TBL] [Abstract][Full Text] [Related]
15. Effects of prolyl hydroxylase inhibitors on adipogenesis and hypoxia inducible factor 1 alpha levels under normoxic conditions.
Floyd ZE; Kilroy G; Wu X; Gimble JM
J Cell Biochem; 2007 Aug; 101(6):1545-57. PubMed ID: 17370314
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
17. Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition.
Chintala S; Najrana T; Toth K; Cao S; Durrani FA; Pili R; Rustum YM
BMC Cancer; 2012 Jul; 12():293. PubMed ID: 22804960
[TBL] [Abstract][Full Text] [Related]
18. The role of hypoxia and Morg1 in renal injury.
Loeffler I; Wolf G
Eur J Clin Invest; 2015 Mar; 45(3):294-302. PubMed ID: 25615026
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products enhance macrophage polarization to the M1 phenotype via the HIF-1α/PDK4 pathway.
Han X; Ma W; Zhu Y; Sun X; Liu N
Mol Cell Endocrinol; 2020 Aug; 514():110878. PubMed ID: 32464167
[TBL] [Abstract][Full Text] [Related]
20. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
